drugset
Drugs / Human Adipose-Derived Stem Cell Exosomes
last change Jan 2026 re-read 3 minutes ago

Human Adipose-Derived Stem Cell Exosomes

also known as ADSC-exo · STX11102

Other / unclassified

Developed for
ischemic stroke
Investigated by
First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University · Shanghai 10th People's Hospital · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai Jiao Tong University Affiliated Sixth People's Hospital · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Trials 1

today NCT07398612 · Ph 1/2
20272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT07398612 Jan 2026 → May 2028 expected ischemic stroke Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Not yet recruiting No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Human Adipose-Derived Stem Cell Exosomes ClinicalTrials.gov intervention name — accepted as the source's own label NCT07398612 ↗
Known as ADSC-exo “This is a Phase I/II, randomized, double-blind, placebo-controlled, single/multiple ascending dose clinical study (Investigator-Initiated Trial, IIT) evaluating the safety and...” NCT07398612 ↗
Known as STX11102 “This is a Phase I/II, randomized, double-blind, placebo-controlled, single/multiple ascending dose clinical study (Investigator-Initiated Trial, IIT) evaluating the safety and...” NCT07398612 ↗
Modality Other / unclassified “This intervention involves the use of allogeneic Human Adipose-Derived Stem Cell Exosomes (ADSC-exo), provided as a sterile nasal spray (STX11102).” NCT07398612 ↗
Route Intranasal “administered intranasally once” NCT07398612 ↗